PMID- 8892055 OWN - NLM STAT- MEDLINE DCOM- 19970129 LR - 20220408 IS - 0946-2716 (Print) IS - 0946-2716 (Linking) VI - 74 IP - 9 DP - 1996 Sep TI - Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. PG - 505-13 AB - Hepatocyte growth factor/scatter factor (HGF/SF) is a pleiotropic effector of cells expressing the Met tyrosine kinase receptor. While HGF/SF-Met signaling clearly plays a role in a variety of normal cellular process, this signaling pathway has also been implicated in the generation and metastatic spread of tumors. This review discusses in detail several model systems that have been developed to investigate the role of HGF/SF-Met signaling in malignancy and describes additional data regarding the expression of these molecules in human tumors. Collectively the findings support a role for this receptor-ligand pair in human malignancy. FAU - Jeffers, M AU - Jeffers M AD - ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, MD 21702, USA. FAU - Rong, S AU - Rong S FAU - Vande Woude, G F AU - Vande Woude GF LA - eng PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PT - Review PL - Germany TA - J Mol Med (Berl) JT - Journal of molecular medicine (Berlin, Germany) JID - 9504370 RN - 67256-21-7 (Hepatocyte Growth Factor) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) SB - IM MH - Animals MH - Gene Expression Regulation/genetics MH - Hepatocyte Growth Factor/*metabolism MH - Humans MH - Mice MH - Models, Biological MH - Neoplasm Metastasis MH - Neoplasms/metabolism MH - Protein-Tyrosine Kinases/metabolism MH - Signal Transduction/physiology MH - Tumor Cells, Cultured RF - 106 EDAT- 1996/09/01 00:00 MHDA- 1996/09/01 00:01 CRDT- 1996/09/01 00:00 PHST- 1996/09/01 00:00 [pubmed] PHST- 1996/09/01 00:01 [medline] PHST- 1996/09/01 00:00 [entrez] AID - 10.1007/BF00204976 [doi] PST - ppublish SO - J Mol Med (Berl). 1996 Sep;74(9):505-13. doi: 10.1007/BF00204976.